A Phase 1 Study of HS130 in Combination With Viagenpumatucel-L (HS110) in Patients With Solid Tumors

NCT04116710 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

BIOLOGICAL: HS-110 (viagenpumatucel-L)
BIOLOGICAL: HS-130

Sponsor

Heat Biologics